<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28615</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Results of human papillomavirus testing on self-collected versus clinician-collected samples</article-title><trans-title-group xml:lang="ru"><trans-title>Результаты тестирования на вирус папилломы человека при самостоятельном и врачебном заборе материала</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belokrinitskaya</surname><given-names>T E</given-names></name><name xml:lang="ru"><surname>Белокриницкая</surname><given-names>Т Е</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><email>tanbell24@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Frolova</surname><given-names>N I</given-names></name><name xml:lang="ru"><surname>Фролова</surname><given-names>Н И</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, ассистент каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><email>taasyaa@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Turanova</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Туранова</surname><given-names>О В</given-names></name></name-alternatives><bio xml:lang="ru"><p>клинический ординатор каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><email>pochta@chitgma.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pletneva</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Плетнева</surname><given-names>В А</given-names></name></name-alternatives><bio xml:lang="ru"><p>студентка, член Молодежного научного общества каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shemyakina</surname><given-names>K N</given-names></name><name xml:lang="ru"><surname>Шемякина</surname><given-names>К Н</given-names></name></name-alternatives><bio xml:lang="ru"><p>студентка, член Молодежного научного общества каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sambueva</surname><given-names>N B</given-names></name><name xml:lang="ru"><surname>Самбуева</surname><given-names>Н Б</given-names></name></name-alternatives><bio xml:lang="ru"><p>студентка, член Молодежного научного общества кафедры акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Maltseva</surname><given-names>E E</given-names></name><name xml:lang="ru"><surname>Мальцева</surname><given-names>Е Е</given-names></name></name-alternatives><bio xml:lang="ru"><p>студентка, член Молодежного научного общества каф. акушерства и гинекологии педиатрического фак-та, ФПК и ППС ФГБОУ ВО ЧитГМА</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Chita State Medical Academy of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2017</year></pub-date><volume>19</volume><issue>1</issue><issue-title xml:lang="en">VOL 19, NO1 (2017)</issue-title><issue-title xml:lang="ru">ТОМ 19, №1 (2017)</issue-title><fpage>56</fpage><lpage>62</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/28615">https://gynecology.orscience.ru/2079-5831/article/view/28615</self-uri><abstract xml:lang="en"><p>Objective - to evaluate the prevalence of high-risk human papillomavirus infection (HR HPV), the efficiency and acceptability on self-collected using the Qvintip device versus clinician-collected samples in vaginal discharge. Subjects and methods. A cross-sectional study involving 200 women attituded to an employer’s outpatient clinic for periodic/annual medical examination. The mean age of the patients was 32.7±6.9 (range: 18-45 years). Vaginal discharge was collected using a Qvintip device and vaginal smear from the cervical canal was taken by a physician for a further HR HPV PCR test. A face-to-face interviews using to assess acceptability of the compared methods. Patients evaluated comfort, pain, privacy and embarrassment using the rating «yes» or «no». Results. 42% of all patients were HR HPV positive. The efficiency of the survey using the self-collected Qvintip device was higher than the clinician-taken samples: 38% vs 27.5% (OR=1.6; pχ2=0.025). The use of the Qvintip device only increased a chance to detect HR-HPV by 5 times: 36.3% vs 9.5% (OR=5.0; pχ2=0.0001). HPV-16 was the most frequently encountered HPV type (17.7%), followed by HPV-56 (16.3%), HPV-39 (13.6%), HPV-31 (10.9%), HPV-33 and HPV-51 (8.2%), HPV-58 (7.5%), HPV-52 (6.1%); HPV-45 (5.4%), HPV-18 (4.1%); HPV-35 (1.4%), HPV-59 (0.7%). 51.2% of HPV-positive women were infected with several types of HR HPV. Two types of HR HPV were detected in 34.5%, three - in 9.5%, four - in 6%, five - in 1.2 % patients. Self-sampling using the Qvintip device was a well-accepted method. Compared to physician-sampling, women reported a preference for self-sampling (64%), as it was more comfortable (75% vs 22.2%, p&lt;0.001) and caused less pain (70.3% vs 22.2%, p&lt;0.001) and less embarrassment (25.8% vs 1.4%, p&lt;0.001). Most preferred to take the self-sample at home in the future (96%) because it was simple and did not require a doctor’s appointment. Conclusion. Reproductive age women show a high rate of HR HPV infection (42%). Vaginal self-sampling using the Qvintip device was more easy and comfortable, and shown higher diagnostic efficiency than the clinician-taken samples. Offering self-sampling for HPV testing may improve screening participation rates and overcome women’s embarrassment regarding clinician examination.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования - выявить распространенность вируса папилломы человека высокого канцерогенного риска (ВПЧ-ВКР) у женщин репродуктивного возраста, дать оценку результативности и приемлемости обследования при самостоятельном и врачебном заборе вагинального отделяемого для ВПЧ-теста. Материалы и методы. Проведено одномоментное кросс-секционное исследование с участием 200 женщин в возрасте 18-45 лет (средний возраст 32,7±6,9 года), обратившихся в поликлинику медосмотров для получения допуска к работе. Забор вагинального отделяемого для исследования на ВПЧ-ВКР методом полимеразной цепной реакции проведен дважды: самостоятельно с помощью прибора Qvintip и врачом из цервикального канала. Приемлемость взятия образцов двумя сравниваемыми методами оценена по результатам опроса пациенток об удобстве, болезненности, конфиденциальности, эмоциональных ощущениях при заборе материала для ВПЧ-теста. Результат. ВПЧ-ВКР выявлен у 42% обследованных. Результативность обследования с помощью устройства Qvintip была выше, чем при заборе материала врачом: 38% vs 27,5% (отношение шансов - ОШ 1,6; pχ2=0,025). Использование только устройства Qvintip повышает шанс выявления ВПЧ-ВКР в 5 раз: 36,3% vs 9,5% (ОШ 5,0; pχ2=0,0001). Частота выявления ВПЧ 16-го типа была наибольшей (17,7%), реже идентифицированы ВПЧ 56 (16,3%), 39 (13,6%), 31 (10,9%), 33 и 51 (по 8,2%), 58 (7,5%), 52 (6,1%), 45 (5,4%), 18 (4,1%), 35 (1,4%), 59-го типа (0,7%). У 51,2% ВПЧ-позитивных женщин обнаружены несколько типов ВПЧ-ВКР: 2 - у 34,5%, 3 - 9,5%, 4 - 6%, 5 - 1,2%. При оценке комплаентности 64% пациенток отдали предпочтение методу самостоятельного забора материала для ВПЧ-теста с помощью устройства Qvintip, 36% - взятию образца врачом (p&lt;0,001). Большая часть женщин отметили, что метод самозабора более комфортный (75% vs 22,2%, р&lt;0,001), менее болезненный (70,3% vs 22,2%, р&lt;0,001), вызывал меньшее смущение (25,8% vs 1,4%, р&lt;0,001). Единственной причиной предпочтения взятия образца врачом является большая уверенность, что материал взят правильно (10,1% vs 84,7%, р&lt;0,001). В будущем предпочтут самостоятельно производить забор материала для ВПЧ-теста 96% женщин, поскольку это просто и не требует визита к врачу. Заключение. У организованных женщин репродуктивного возраста высока распространенность ВПЧ-ВКР-инфицирования (42%). Устройство Qvintip для самостоятельного взятия образца ДНК ВПЧ обладает высокой диагностической эффективностью, простое и удобное в использовании. Высокая комплаентность пациенток к самостоятельному взятию образцов ДНК ВПЧ может повысить численность женщин, участвующих в программах цервикального скрининга.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Qvintip</kwd><kwd>high-risk human papillomavirus</kwd><kwd>HPV-test</kwd><kwd>self sampling</kwd><kwd>cervix uteri</kwd><kwd>Qvintip</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирус папилломы человека высокого канцерогенного риска</kwd><kwd>ВПЧ-тест</kwd><kwd>самозабор</kwd><kwd>шейка матки</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bruni L, Barrionuevo-Rosas L, Albero G et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 15 December 2016.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Comprehensive Cervical Cancer Control. A guide to essential practice Second edition. World Health Organization, 2014.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women. World Health Organization, 2013.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Профилактика рака шейки матки. Под ред. Г.Т.Сухих, В.Н.Прилепской. Руководство для врачей. М.: МЕДпресс-информ, 2012.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. World Health Organization, 2013.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Bosch F.X, Broker T.R, Forman D et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine 2013; 31 (Suppl. 7): H1-31.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Lorincz A, Castanon A, Wey Wey Lim A, Sasieni P. New Strategies for HPV-based Cervical Screening. Womens Health (Lond Engl) 2013; 9 (5). DOI: 10.2217/whe.13.48 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880859/</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Wright T.C, Stoler M.H, Behrens C.M et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first - line screening test. Gynecol Oncol 2015; 136 (2): 189-97.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Martins T.R, de Oliveira C.M, Rosa L.R et al. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data. Virol J 2016; 13: 138.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Katki H.A, Kinney W.K, Fetterman B et al. Cervical Cancer Risk for 330,000 Women Undergoing Concurrent HPV Testing and Cervical Cytology in Routine Clinical Practice at a Large Managed Care Organization. Lancet Oncol 2011; 12 (7): 663-72.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Agorastos T, Chatzistamatiou K, Katsamagkas T et al. and the HERMES study group. Primary Screening for Cervical Cancer Based on High - Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology. PLoS One 2015; 10 (3): e0119755. DOI: 10.1371/journal.pone.0119755. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368762/</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Deleré Y, Schuster M, Vartazarowa E et al. Cervicovaginal Self-Sampling Is a Reliable Method for Determination of Prevalence of Human Papillomavirus Genotypes in Women Aged 20 to 30 Years. J Clin Microbiol 2011; 49 (10): 3519-22.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Arbyn M, Verdoodt F, Snijders PJ et al. Accuracy of human papillomavirus testing on self - collected versus clinician - collected samples: a meta - analysis. Lancet Oncol 2014; 15 (2): 172-83. DOI: 10.1016/S1470-2045(13)70570-9.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Chen K, Ouyang Y, Hillemanns P, Jentschke M. Excellent analytical and clinical performance of a dry self - sampling device for human papillomavirus detection in an urban Chinese referral population. J Obstet Gynaecol Res 2016; 42 (12): 1839-45. DOI: 10.1111/jog.13132.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Del Mistro A, Frayle H, Ferro A et al. Efficacy of self - sampling in promoting participation to cervical cancer screening also in subsequent round. Prev Med Rep 2016; 5: 166-68. DOI: 10.1016/j.pmedr.2016.12.017. eCollection 2017.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Wong E.L.Y, Chan Paul K.S, Chor J.S.Y et al. Evaluation of the Impact of Human Papillomavirus DNA Self - sampling on the Uptake of Cervical Cancer Screening. Cancer Nurs 2016; 39 (1): E1-E11.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Jentschke M, Chen K, Arbyn M et al. Direct comparison of two vaginal self - sampling devices for the detection of human papillomavirus infections. J Clin Virol 2016; 82: 46-50. DOI: 10.1016/j.jcv.2016.06.016.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Ma'som M, Bhoo-Pathy N, Nasir N.H et al. Attitudes and factors affecting acceptability of self - administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women. BMJ Open 2016; 6 (8): e011022. DOI: 10.1136/bmjopen-2015-011022.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Silva J, Cerqueira F, Medeiros R. Acceptability of self - sampling in Portuguese women: the good, the bad or the ugly? Sex Health 2017. DOI: 10.1071/SH16077.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Sultana F, Mullins R, English D.R et al. Women’s experience with home - based self - sampling for human papillomavirus testing. BMC Cancer 2015; 15: 849.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Boggan J.C, Walmer D.K, Henderson G et al. Vaginal self - sampling for human papillomavirus infection as a primary cervical cancer screening tool in a naitian population. Sex Transm Dis 2015; 42 (11): 655-9.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Zhao F.H, Lewkowitz A.K, Chen F et al. Pooled analysis of a self - sampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012; 104 (3): 178-88.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Balasubramanian A, Kulasingam S.L, Baer A et al. Accuracy and cost - effectiveness of cervical cancer screening by high - risk human papillomavirus DNA testing of self - collected vaginal samples. J Lower Genit Tract Dis 2010; 14 (3): 185-95.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bhatla N, Dar L, Patro A.R et al. Can human papillomavirus DNA testing of self - collected vaginal samples compare with physician - collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009; 33 (6): 446-50.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Szarewski A, Cadman L, Mallett S et al. Human papillomavirus testing by self - sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007; 14 (1): 34-42.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Артымук Н.В., Марочко К.В. Эффективность выявления вируса папилломы человека при помощи устройства для самостоятельного забора вагинального отделяемого. Акушерство и гинекология. 2016; 3: 85-91.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Wright T.C.Jr, Denny L, Kuhn L et al. HPV DNA testing of self - collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283 (1): 81-6.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Haguenoer K, Sengchanh S, Gaudy-Graffin C et al. Vaginal self - sampling is a cost - effective way to increase participation in a cervical cancer screening programme: a randomised trial. Br J Cancer 2014; 111 (11): 2187-96. DOI: 10.1038/bjc.2014.510.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Bansil P, Wittet S, Lim J.L et al. Acceptability of self - collection sampling for HPV-DNA testing in low - resource settings: a mixed methods approach. BMC Public Health 2014; 14: 596.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Doorbar J, Egawa N, Griffin H et al. Human papillomavirus molecular biology and disease association. Rev Med Virol 2015; 25 (Suppl. 1): 2-23. DOI: 10.1002/rmv.1822.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Rogovskaya S.I, Shabalova I.P, Mikheeva I.V et al. Human papillomavirus prevalence and type - distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia. Vaccine 2013; 31 (Suppl. 7): H46-58. DOI: 10.1016/j.vaccine.2013.06.043.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Белокриницкая Т.Е., Фролова И.И., Тарбаева Д.А. и др. Конфаундинг - факторы папилломавирусной инфекции и цервикальной дисплазии у молодых женщин. Доктор.Ру. 2015; 14 (115): 7-12.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Мерзлякова М.К., Никитина Е.Г., Бычков В.А. и др. Сравнительные аспекты распространенности генотипов вируса папилломы человека у женского населения Томской области и Республики Тыва. Сиб. онкол. журн. 2012; Прил. 1: 108-9.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Основные показатели деятельности акушерско - гинекологической службы в Российской Федерации в 2015 году. Под ред. Е.Н.Байбариной. М., 2016.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Zehbe I, Jackson R, Wood B et al. Community - randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self - sampling versus Papanicolaou cytology. BMJ Open 2016; 6 (10): e011754.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Ortiz A.P, Alejandro N, Pérez C.M et al. Acceptability of Cervical and Anal HPV Self - sampling in a Sample of Hispanic Women in Puerto Rico. PR Health Sci J 2012; 31 (4): 205-12.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Darlin L, Borgfeldt C, Forslund O et al. Comparison of use of vaginal HPV self - sampling and offering flexible appointments as strategies to reach long - term non - attending women in organized cervical screening. J Clin Virol 2013; 58 (1): 155-60.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Verdoodt F, Jentschke M, Hillemanns P et al. Reaching women who do not participate in the regular cervical cancer screening programme by offering self - sampling kits: a systematic review and meta - analysis of randomised trials. Eur J Cancer 2015; 51 (16): 2375-85. DOI: 10.1016/j.ejca.2015.07.006. https://www.ncbi.nlm.nih.gov/pubmed/26296294.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Chou H.H, Huang H.J, Cheng H.H et al. Self - sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under - screening in Taiwan. J Formos Med Assoc 2015; pii: S0929-6646(15)00353-8. DOI: 10.1016/j.jfma.2015.10.014.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Tranberg M, Bech B.H, Blaakær J et al. Study protocol of the CHOiCE trial: a three - armed, randomized, controlled trial of home - based HPV self - sampling for non - participants in an organized cervical cancer screening program. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094020/</mixed-citation></ref></ref-list></back></article>
